Cargando…
Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study
The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839851/ https://www.ncbi.nlm.nih.gov/pubmed/27082607 http://dx.doi.org/10.1097/MD.0000000000003384 |
_version_ | 1782428201488744448 |
---|---|
author | Kim, Nan Hee Seo, Ji A Cho, Hyunjoo Seo, Ji Hye Yu, Ji Hee Yoo, Hye Jin Kim, Sin Gon Choi, Kyung Mook Baik, Sei Hyun Choi, Dong Seop Shin, Chol Cho, Nam Han |
author_facet | Kim, Nan Hee Seo, Ji A Cho, Hyunjoo Seo, Ji Hye Yu, Ji Hee Yoo, Hye Jin Kim, Sin Gon Choi, Kyung Mook Baik, Sei Hyun Choi, Dong Seop Shin, Chol Cho, Nam Han |
author_sort | Kim, Nan Hee |
collection | PubMed |
description | The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and whether consistency of this phenotype or age affected cardiometabolic outcomes. We recruited 7588 subjects without diabetes or CVD, aged 40 to 69 years at baseline examination, from the Korean Genome and Epidemiology Study, and followed-up these subjects for 10 years biennially. Participants were divided into 4 groups based on the body mass index and the presence of metabolic syndrome: metabolically healthy normal weight (MHNW), MHO, metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). We defined persistent phenotypes if subjects maintained the same phenotype at every visit from baseline to their last visit. Incident diabetes and CVD morbidity or mortality were identified during 10 years of follow-up. Compared to MHNW controls, MUNW and MUO groups had increased risk for development of diabetes (hazard ratio [HR] 3.0 [95% CI: 2.5–3.6], and 4.0 [3.4–4.7], respectively) and CVD (HR 1.6 [1.3–2.0], and 1.9 [1.5–2.4], respectively). However, the MHO group showed only a marginal increase in risk for diabetes and CVD (HR 1.2 [0.99–1.6], 1.4 [0.99–1.8], respectively). The impact of MHO on the development of diabetes was more prominent in younger individuals (HR 1.9 [1.2–3.1] vs 1.1 [0.8–1.4], <45 years vs ≥45 years at baseline). Only 15.8% of MHO subjects maintained the MHO phenotype at every visit from baseline to the 5th biennial examination (persistent MHO). In subjects with persistent MHO, the risk for diabetes and CVD was significantly higher than those with persistent MHNW (1.9 [1.2–3.1], 2.1 [1.2–3.7], respectively). MHO phenotype, even if maintained for a long time, was associated with a significantly higher risk for the development of diabetes and CVD in Korean subjects. |
format | Online Article Text |
id | pubmed-4839851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-48398512016-06-02 Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study Kim, Nan Hee Seo, Ji A Cho, Hyunjoo Seo, Ji Hye Yu, Ji Hee Yoo, Hye Jin Kim, Sin Gon Choi, Kyung Mook Baik, Sei Hyun Choi, Dong Seop Shin, Chol Cho, Nam Han Medicine (Baltimore) 4300 The reported effects of a metabolically healthy obese (MHO) phenotype on diabetes and cardiovascular disease (CVD) risk are contradictory. Within the context of a population-based cohort study, we aimed to investigate the long-term risk of an MHO status for the development of diabetes and CVD, and whether consistency of this phenotype or age affected cardiometabolic outcomes. We recruited 7588 subjects without diabetes or CVD, aged 40 to 69 years at baseline examination, from the Korean Genome and Epidemiology Study, and followed-up these subjects for 10 years biennially. Participants were divided into 4 groups based on the body mass index and the presence of metabolic syndrome: metabolically healthy normal weight (MHNW), MHO, metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). We defined persistent phenotypes if subjects maintained the same phenotype at every visit from baseline to their last visit. Incident diabetes and CVD morbidity or mortality were identified during 10 years of follow-up. Compared to MHNW controls, MUNW and MUO groups had increased risk for development of diabetes (hazard ratio [HR] 3.0 [95% CI: 2.5–3.6], and 4.0 [3.4–4.7], respectively) and CVD (HR 1.6 [1.3–2.0], and 1.9 [1.5–2.4], respectively). However, the MHO group showed only a marginal increase in risk for diabetes and CVD (HR 1.2 [0.99–1.6], 1.4 [0.99–1.8], respectively). The impact of MHO on the development of diabetes was more prominent in younger individuals (HR 1.9 [1.2–3.1] vs 1.1 [0.8–1.4], <45 years vs ≥45 years at baseline). Only 15.8% of MHO subjects maintained the MHO phenotype at every visit from baseline to the 5th biennial examination (persistent MHO). In subjects with persistent MHO, the risk for diabetes and CVD was significantly higher than those with persistent MHNW (1.9 [1.2–3.1], 2.1 [1.2–3.7], respectively). MHO phenotype, even if maintained for a long time, was associated with a significantly higher risk for the development of diabetes and CVD in Korean subjects. Wolters Kluwer Health 2016-04-18 /pmc/articles/PMC4839851/ /pubmed/27082607 http://dx.doi.org/10.1097/MD.0000000000003384 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 4300 Kim, Nan Hee Seo, Ji A Cho, Hyunjoo Seo, Ji Hye Yu, Ji Hee Yoo, Hye Jin Kim, Sin Gon Choi, Kyung Mook Baik, Sei Hyun Choi, Dong Seop Shin, Chol Cho, Nam Han Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title | Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title_full | Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title_fullStr | Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title_full_unstemmed | Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title_short | Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study |
title_sort | risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: the korean genome and epidemiology study |
topic | 4300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839851/ https://www.ncbi.nlm.nih.gov/pubmed/27082607 http://dx.doi.org/10.1097/MD.0000000000003384 |
work_keys_str_mv | AT kimnanhee riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT seojia riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT chohyunjoo riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT seojihye riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT yujihee riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT yoohyejin riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT kimsingon riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT choikyungmook riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT baikseihyun riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT choidongseop riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT shinchol riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy AT chonamhan riskofthedevelopmentofdiabetesandcardiovasculardiseaseinmetabolicallyhealthyobesepeoplethekoreangenomeandepidemiologystudy |